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https://doi.org/10.1053/j.gastro.2017.07.047BACKGROUND & AIMS: Interactions between commensal mi-
crobes and the immune system are tightly regulated and
maintain intestinal homeostasis, but little is known about these
interactions in humans. We investigated responses of human
CD4þ T cells to the intestinal microbiota. We measured the
abundance of T cells in circulation and intestinal tissues that
respond to intestinal microbes and determined their clonal
diversity. We also assessed their functional phenotypes and
effects on intestinal resident cell populations, and studied al-
terations in microbe-reactive T cells in patients with chronic
intestinal inﬂammation. METHODS: We collected samples of
peripheral blood mononuclear cells and intestinal tissues
from healthy individuals (controls, n ¼ 1330) and patients
with inﬂammatory bowel diseases (n ¼ 119; 59 with ulcer-
ative colitis and 60 with Crohn’s disease). We used 2 inde-
pendent assays (CD154 detection and carboxy-ﬂuorescein
succinimidyl ester dilution assays) and 9 intestinal bacterial
species (Escherichia coli, Lactobacillus acidophilus, Biﬁdo-
bacterium animalis subsp lactis, Faecalibacterium prausnitzii,
Bacteroides vulgatus, Roseburia intestinalis, Ruminococcus
obeum, Salmonella typhimurium, and Clostridium difﬁcile) to
quantify, expand, and characterize microbe-reactive CD4þ
T cells. We sequenced T-cell receptor Vb genes in expanded
microbe-reactive T-cell lines to determine their clonal di-
versity. We examined the effects of microbe-reactive CD4þ
T cells on intestinal stromal and epithelial cell lines. Cytokines,
chemokines, and gene expression patterns were measured by
ﬂow cytometry and quantitative polymerase chain reaction.
RESULTS: Circulating and gut-resident CD4þ T cells from
controls responded to bacteria at frequencies of 404000 per
million for each bacterial species tested. Microbiota-reactive
CD4þ T cells were mainly of a memory phenotype, present in
peripheral blood mononuclear cells and intestinal tissue, and
had a diverse T-cell receptor Vb repertoire. These cells werefunctionally heterogeneous, produced barrier-protective cyto-
kines, and stimulated intestinal stromal and epithelial cells via
interleukin 17A, interferon gamma, and tumor necrosis factor.
In patients with inﬂammatory bowel diseases, microbiota-
reactive CD4þ T cells were reduced in the blood compared
with intestine; T-cell responses that we detected had an
increased frequency of interleukin 17A production compared
with responses of T cells from blood or intestinal tissues of
controls. CONCLUSIONS: In an analysis of peripheral blood
mononuclear cells and intestinal tissues from patients with
inﬂammatory bowel diseases vs controls, we found that
reactivity to intestinal bacteria is a normal property of the
human CD4þ T-cell repertoire, and does not necessarily indi-
cate disrupted interactions between immune cells and the
commensal microbiota. T-cell responses to commensals might
support intestinal homeostasis, by producing barrier-protective
cytokines and providing a large pool of T cells that react to
pathogens.Keywords: Immune Regulation; Microbiota; Cytokines; Tissue-
resident Memory T cells.
EDITOR’S NOTES
BACKGROUND AND CONTEXT
CD4þ T cell responses to intestinal bacteria are known to
occur, however these responses remain poorly
characterized in humans.
NEW FINDINGS
Microbiota-reactive CD4þ T cells are prevalent and
normal constituents of the human immune system that
are functionally altered during IBD pathogenesis.
LIMITATIONS
The functional relevance of the detected T-cell responses
in humans remains to be elucidated.
IMPACT
T-cell responses to commensals might support intestinal
homeostasis by producing barrier-protective cytokines
and providing a large pool of T cells with potential
cross-reactivity to pathogens.
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barrier integrity, and development of appropriately
educated mucosal immunity.1 Intestinal immune responses
are tightly regulated to allow protective immunity against
pathogens, while limiting responses to dietary antigens and
innocuous microbes. The “mucosal ﬁrewall” prevents sys-
temic dissemination of microbes by conﬁning microbial
antigens to the gut-associated lymphoid tissue.2 In the gut-
associated lymphoid tissue, dendritic cells drive regulatory
T-cell differentiation in response to dietary antigens and
commensal bacteria.3 Nevertheless, vast numbers of
potentially commensal-reactive effector and memory T cells
populate intestinal mucosae.4 Recent evidence suggests that
in mice, tolerance to commensal-derived antigens may be
lost during pathogen-induced epithelial damage and sub-
sequent transient exposure to commensals.1,5 In humans,
circulating memory T cells recognize peptides derived from
gut bacteria and can cross-react to pathogens, which can
confer immunologic advantage during subsequent new in-
fections.6,7 Although this process can be beneﬁcial during
homeostasis, deranged responses to commensals may pro-
mote inﬂammatory conditions, such as inﬂammatory bowel
diseases (IBDs).
IBDs (including Crohn’s disease and ulcerative colitis)
result from a prolonged disturbance of gut homeostasis, the
precise etiology of which is uncertain. One hypothesis is
that, in genetically susceptible individuals, IBD may be
triggered by intestinal dysbiosis that promotes aberrant
immune stimulation.8 Indeed, in mouse models of colitis,
intestinal microbiota promote inﬂammation in part by
stimulating microbiota-reactive CD4þ T cells.5,9 Whether
this drives IBD in humans, however, remains unknown.
Although CD4þ T-cell responses to intestinal bacteria
are known to occur in humans,10–12 several aspects of this
topic are largely uncharacterized, including the frequency
of human T cells in the gut and periphery that are reactiveto phylogenetically distinct intestinal microbes; the T-cell
receptor (TCR) diversity and clonotype sharing of these T
cells; the functional phenotype of gut microbe-reactive T
cells and their impact on tissue-resident cell populations;
and how microbe-reactive T cells change during chronic
intestinal inﬂammation. To address this knowledge gap,
we extensively characterized CD4þ T-cell responses to
intestinal microbiota in healthy individuals and IBD
patients.
Using 2 independent assays, we observed that for almost
all enteric bacteria examined, bacteria-reactive CD4þ T cells
were present at a frequency of 40500 per million CD4þ T
cells in adult peripheral blood. Bacteria-reactive T cells were
also prevalent in the gut mucosa, with prominent enrich-
ment for proteobacteria reactivity. Microbiota-responsive T
cells showed a diverse TCR Vb repertoire and potently
stimulated inﬂammatory responses by intestinal epithelial
and stromal cells. Intriguingly, T cells from IBD patients
displayed a normal spectrum of microbial responses, but
expressed high amounts of interleukin (IL) 17A, consistent
with increased amounts of T-helper (Th) 17-polarizing cy-
tokines in inﬂamed intestinal tissue. Collectively, these data
demonstrate that microbiota-reactive CD4þ T cells are
prevalent and normal constituents of the human immune
system that are functionally altered during IBD
pathogenesis.Materials and Methods
Human Samples and Cell Isolation
Leukoreduction chambers from healthy individuals were
obtained from the National Blood Service (Bristol, UK). Pe-
ripheral EDTA blood samples were obtained from IBD patients
attending the John Radcliffe Hospital Gastroenterology unit or
from healthy in-house volunteers. IBD patients (n ¼ 119; ul-
cerative colitis, n ¼ 59; Crohn’s disease, n ¼ 60) diagnosed by
endoscopic, histologic, and radiologic criteria were recruited
for the study. Healthy volunteers (n ¼ 30) without any known
underlying acute or chronic pathologic condition served as
control donors. All donors provided informed written consent.
The National Health Service Research Ethics System provided
ethical approval (reference numbers 09/H0606/5 for IBD pa-
tients and 11/YH/0020 for controls; OCHRe ref 15/A237 for
cord blood samples). For details regarding cell isolation, see
Supplementary Experimental Procedures.CD154-Based Detection of Antigen-Speciﬁc
T Cells
CD154 detection was done as described previously.13,14
Brieﬂy, cells were plated at 5  106/cm2 for 712 hours
with heat-inactivated bacteria. Brefeldin A (5 mg/mL; Sigma
Aldrich, St Louis, MO) was added at 2 hours. After 812 hours,
cells were harvested and treated as described in the section on
intracellular cytokine, CD154, and transcription factor staining.
For magnetic cell separation enrichment of CD4þCD154þ T
cells, see Supplementary Experimental Procedures.
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(Carboxy-Fluorescein Succinimidyl Ester Dilution
Assay) and T-Cell Culture
Memory CD4þ CD45ROþ CD45RA T cells were enriched
from peripheral blood mononuclear cells (PBMCs) with un-
touched memory CD4þ T cell enrichment kit (Miltenyi Bio-
tec, Bergisch Gladbach, Germany), sorted to >97% purity on
a FACS ARIA III (BD, San Jose, CA) using CD45RA and
CD45RO expression, and were labeled with carboxy-
ﬂuorescein succinimidyl ester (CFSE) or violet proliferation
dye (Invitrogen, Carlsbad, CA). CD14þ monocytes were iso-
lated from PBMC using anti-CD14 microbeads (Miltenyi
Biotec), irradiated (45 Gy) and then pre-incubated for 3
hours with bacterial lysates before T-cell co-culture. T cells
were co-cultured with the irradiated autologous monocytes
at a ratio of 2:1 for 57 days. Cells were cultured in RPMI-
1640 supplemented with 2 mM glutamine, 1% (v/v) non-
essential amino acids, 1% (v/v) sodium pyruvate, penicillin
(50 U/mL), streptomycin (50 mg/mL; all from Invitrogen),
and 5% (v/v) human serum (National Blood Service, Bristol,
UK). CD14þ monocytes were irradiated (45 Gy) and then
pre-incubated for 3 hours with bacterial lysates before T-cell
co-culture. For major histocompatibility complex II blockade,
10 mg/mL of a pan-HLA class-II blocking antibody (HLA-DR,
DP, DQ [Tü39]) was added 30 minutes before T-cell co-
culture. T-cell lines were generated by sorting CFSElow
inducible T-cell costimulator (ICOS)high CD4þ T cells after 7
days of stimulation and expanding them with IL2 (300 U/
mL) and anti-CD3/CD28 beads (beads/T cell ratio, 1:4,
Dynals) for 1014 days. Supernatants were collected from
1  106 CD4þ T cells stimulated for 24 hours with phorbol
myristate acetate (5 ng/mL) and ionomycin (500 ng/mL;
Sigma).B
TR
ANFlow Cytometry and Cell Sorting
PBMCs and lamina propria mononuclear cells were stained
according to standard protocols. For details, see Supplementary
Experimental Procedures.Intracellular Cytokine, CD154, and Transcription
Factor Staining
For intracellular cytokine staining, cells were stained with
ﬁxable viability dye eFluor 780 (eBioscience, San Diego, CA)
and surface markers, ﬁxed with 2% formaldehyde (Merck,=
Figure 1. Healthy adults possess circulating memory CD4þ T
stimulated with heat-inactivated bacteria for 812 hours, and
CD154 expression. (A) Experimental setup. (B) CD154þ fre
short-term stimulation with heat-inactivated bacteria (n ¼ 30 i
per million CD4þ T cells in adult blood (n ¼ 30). The numbers
frequencies of CD4þCD154þ T cells. Background (no microb
Signiﬁcance calculated in relation to lipopolysaccharide stimul
T cells in adult (n ¼ 30) or cord blood (n ¼ 3) after short-term
of CD45RA on CD4þCD154þ T cells, showing 4 representat
quencies of memory cells within CD4þCD154þ T cells. Each
individual (n ¼ 1930). (G) Expression of CD45RA, TNF-a,
stimulation with bacterial lysates. Statistics: (B, C, F) 1-way
(D) Mann-Whitney test.Kenilworth, NJ), and stained for cytokines in magnetic cell
separation buffer containing 0.05% saponin (Sigma-Aldrich).
Transcription factor expression was analyzed using the FoxP3
staining buffer set (eBioscience) according to manufacturer’s
instructions.
Stimulation of Intestinal Cell Lines
CCD18Co (non-transformed human colon ﬁbroblasts; ATCC,
Manassas, VA), and LIM1863 (human colon epithelial cells; a
kind gift of Dr Robert Whitehead, Ludwig Institute for Cancer
Research) cells were cultured in humidiﬁed incubators with 5%
CO2 at 37C in Dulbecco’s modiﬁed Eagle medium or RPMI
media (Sigma) with 10% fetal calf serum (Sigma) and 100 U
penicillin/0.1 mg/mL streptomycin. Cells were stimulated with
5% T-cell supernatants for 24 hours. Cytokine neutralization
was achieved by supernatant pre-incubation for 12 hours
with 10 mg/mL antiIL17A (eBio64CAP17), antiinterferon
(IFN) gamma (B27), antitumor necrosis factor (TNF)a
(Remicade; Janssen Biotech, Horsham, PA), and antiIL22
(IL22JOP).
Statistics
Statistical analyses were performed with GraphPad Prism,
version 6.0 for Macintosh (GraphPad Software, La Jolla, CA).
Statistically signiﬁcant P values were indicated as follows: NS,
not signiﬁcant; *P  .05; **P  .01; ***P  .001; ****P  .0001.
Tests are speciﬁed in ﬁgure legends.
Results
Healthy Adults Possess Circulating
Memory CD4þ T Cells That Are Reactive to
Intestinal Microbiota
CD154 (also known as CD40 ligand) is rapidly
up-regulated by CD4þ T cells after antigen stimulation,
irrespective of their differentiation phenotype, major his-
tocompatibility complex alleles, or the precise nature of the
antigenic epitope.13,14 We therefore used CD154 to detect
naïve and memory CD4þ T-cell responses among PBMCs
after stimulation with heat-inactivated bacteria (Figure 1A).
Seven aerobic and anaerobic intestinal bacterial species
representing the 4 dominant gut phyla were chosen:
Escherichia coli, Lactobacillus acidophilus, Biﬁdobacterium
animalis subsp. lactis, Faecalibacterium prausnitzii,cells that are reactive to intestinal microbiota. PBMCs were
bacteria-reactive CD4þ T cells were detected by intracellular
quencies among peripheral CD4þ T cells in adults after
ndependent donors). (C) Estimated microbiota-reactive cells
of microbiota-reactive T cells were calculated based on the
e stimulation) was subtracted from bacterial stimulations.
ation. (D) Frequencies (±SEM) of CD154þ cells among CD4þ
stimulation with heat-inactivated bacteria. (E) Expression
ive stimulations of the same donor. (F) Mean (±SEM) fre-
symbol represents an antigen-reactive population from one
and IL2 by CD4þCD154þ T cells after short-term PBMC
analysis of variance with Sidak’s multiple comparison test;
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coccus obeum (Supplementary Figure 1A and
Supplementary Table 1). These bacteria are common in the
healthy intestine, but are altered in relative abundance
during inﬂammation.15,16 Furthermore, we analyzed re-
sponses to Salmonella typhimurium and Clostridium difﬁcile
due to their association with IBD.17,18 T-cell responses to
these bacteria were compared with those against well-
characterized barrier surface-related microbes that drive
robust Th17 responses (Staphylococcus aureus and Candida
albicans) or strong Th1 responses (Mycobacterium tuber-
culosis).19,20 The presence of a large pool of M tuberculosis-
reactive memory Th1 cells in non-exposed individuals has
been documented previously. The responses in healthy
controls are directed toward non-tuberculous mycobacteria
rather than toward M tuberculosis.19,21,22 The superantigen
Staphylococcus enterotoxin B (SEB) was used as a positive
stimulation control.
Stimulation with enteric bacteria reproducibly induced
detectable numbers of CD4þCD154þ T cells in the periph-
eral blood. CD4þ T cells reactive to S aureus, C albicans, and
M tuberculosis were generally more abundant (Figure 1B
and Supplementary Figure 1B and C).
Activation markers CD69 and ICOS were up-regulated
on activated antigen-reactive CD4þCD154þ T cells
(Supplementary Figure 1D). Responses were major histo-
compatibility complex IIdependent (Supplementary
Figure 1E), and lipopolysaccharide failed to induce
CD154 expression, conﬁrming that CD154 up-regulation
was not a consequence of non-speciﬁc microbial re-
sponses (Figure 1B and Supplementary Figure 1C). Based
on CD154þ cell frequencies, we calculated that enteric
bacteria-reactive CD4þ T cells were present at precursor
frequencies of 40500 cells per 106 circulating CD4þ T
cells for almost all enteric bacteria surveyed (Figure 1C
and Supplementary Figure 1F).
The newborn gut is primarily colonized with maternal
vaginal and fecal bacteria after birth.23 To understand
whether T-cell reactivity to microbes develops after birth,
we compared CD154 expression in umbilical cord blood
with adult blood after enteric bacteria stimulation. As ex-
pected, appreciable responses to microbiota were
observed only in adult blood. However, CD4þCD154þ=
Figure 2. Circulating microbiota-reactive CD4þ T cells express
CD4þCD154þ T cells were analyzed by ﬂow cytometry after mag
heat-inactivated bacteria. (A) Experimental setup and enrichm
CD45RA and CCR7 expression on enriched CD4þCD154þ T c
graph). Frequencies (±SEM) of 4 independent experiments a
depicting mean frequencies of surface marker and chemokine re
independent donors). (D) Surface marker and chemokine recep
short-term stimulation with B animalis. Data representative of 5
cules with CCR6 after short-term stimulation of CD4þCD154þ
analysis shows each possible combination of CCR7, CCR4, CCR
chemokine receptor expression frequencies among total mem
stimulation with B animalis, S aureus, M tuberculosis, C albic
ments are depicted with n ¼ 58 independent donors. Statisti
parison test.T-cell frequencies after SEB stimulation were similar be-
tween adult and cord blood (Figure 1D and Supplementary
Figure 1G).
Human memory T cells down-regulate the naïve marker
CD45RA and produce cytokines more efﬁciently than naïve
T cells.24,25 In healthy individuals, the majority of bacteria-
reactive CD4þ T cells had a memory phenotype (>80%,
on average), indicating that they had been primed in vivo
(Figure 1E and F and Supplementary Figure 2A and B).
Microbiota-reactive CD4þCD154þCD45RA T cells
expressed high amounts of TNF-a and IL2 when compared
to CD4þCD154þCD45RAþ T cells (Figure 1G
and Supplementary Figure 2C). Therefore, the circulating
pool of memory CD4þ T cells contains numerous
microbiota-reactive cells that arise after birth and produce
cytokines, including TNF-a and IL2.Circulating Microbiota-Reactive CD4þ
T Cells Express Surface Molecules That Permit
Mucosal Trafﬁcking
Memory T cells express numerous adhesion molecules
and chemokine receptors to access different tissues under
steady-state and inﬂammatory conditions.4,26,27 For
example, a4b7 integrin and chemokine receptor (CCR) 9
regulate T-cell migration to distinct parts of the gut.
Blockade of a4b7 integrin has shown clinical efﬁcacy for
treating IBD, whereas CCR9 blockade yielded mixed re-
sults.28,29 To identify homing receptors expressed by
bacteria-reactive CD4þ T cells, we enriched CD4þCD154þ
T cells using magnetic beads to visualize rare enteric-
bacteria-reactive T cells, and analyzed them by ﬂow
cytometry (Figure 2A). Microbiota-reactive T cells had a
central memory phenotype, with >60% expressing high
levels of CCR7 (Figure 2B). Furthermore, 5%10% of
CD4þCD154þ T cells expressed the gut-homing surface
markers integrin b7 and CCR9 (Figure 2C and D). Relative
to total memory CD4þ T cells and CD4þCD154 T cells,
enteric bacteria-reactive T cells had high expression of the
mucosa-homing receptors CCR4 and CCR6 (>60%), low
expression of CCR10, and comparable expression of
CXCR3 and CCR2 (Figure 2D and Supplementary
Figure 2D). Microbiota-reactive CD4þ T cells alsoseveral surface molecules that promote mucosal trafﬁcking.
netic enrichment following short-term PBMC stimulation with
ent efﬁciency after stimulation with SEB. (B) Representative
ells. Central memory T-cell frequencies are shown (right bar
re depicted with n ¼ 8 independent donors. (C) Heat map
ceptor expression on enriched CD4þCD154þ T cells (n ¼ 58
tor expression frequencies among CD4þCD154þ T cells after
8 independent donors. (E) Co-expression of surface mole-
CD45RA T cells with B animalis (left panel). Boolean gating
6, and CD161 expression (right panel). (F) Surface marker and
ory CD4þ T cells and CD4þCD154þ T cells after short-term
ans, or SEB. Frequencies (±SEM) of 4 independent experi-
cs: (F) 1-way analysis of variance with Sidak’s multiple com-
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Th17 cells (Figure 2D and E). The majority of memory
CD4þCD154þ T cells co-expressed CCR7, CCR4, CD161,
and CCR6 in various combinations, some of which also
expressed integrin b7 (Figure 2E, pie chart). Therefore,
circulating microbiota-reactive CD4þ T cells are equipped
with several homing receptors that promote mucosal
access.
When comparing gut microbiota-reactive CD4þ T cells
with those reactive to non-enteric organisms (including S
aureus, M tuberculosis, and C albicans), enteric bacteria-
reactive T cells were partially enriched only in CCR4
expression (Figure 2F). The homing receptor phenotype of
enteric bacteria-reactive T cells is consistent with that of T
cells reactive to a broad diversity of microbes located at
barrier surfaces.Microbiota-Reactive CD4þ T Cells Are Enriched
in Gut Tissue
The gut harbors >3  1010 CD4þ T cells, but their
speciﬁcity is unknown.4,5 We therefore estimated the
abundance of human microbiota-reactive CD4þ T cells in
the gut by examining non-inﬂamed colon specimens using
the CD154 assay (Figure 3A). Lamina propria CD4þ T cells
showed a dominant effector memory and central memory
phenotype and expressed both tissue-resident and gut-
related markers, with 80% of cells being CD69þ
(Supplementary Figure 3A).
We next stimulated lamina propria mononuclear cells
with microbial lysates or SEB. We combined intracellular
CD154 detection with TNF-a staining to increase assay
sensitivity, as lamina propria CD4þ T cells expressed low
amounts of CD154 without stimulation (Supplementary
Figure 3B and C). Compared with peripheral blood fre-
quencies of unrelated donors, there were similar fre-
quencies of S aureus and SEB reactivity, and reduced M
tuberculosis-reactivity in the gut. However, gut CD4þ T cells
were enriched in reactivity toward intestinal bacteria and C
albicans (Figure 3B and Supplementary Figure 3D).
Bacteria-reactive cells comprised 1504000 cells per 106
gut-resident memory CD4þ T cells for all enteric bacteria
tested. Given that peripheral blood contained 40500
bacteria-reactive cells per 106 memory CD4þ T cells (for
each bacteria tested), this suggests that bacteria-reactive T
cells are 3- to 8-fold more frequent in gut tissue as
compared with those in circulation. The strong enrichment
of S typhimurium and E coli reactivity in the gut was
conﬁrmed by assessing CD154 and TNF-a expression in
CD4þ T cells from donor-matched blood and intestinal tis-
sue (Figure 3C). Because the gut harbors up to 3  1010
memory T cells (vs 510  109 in blood),4 many of which
are bacteria-reactive, the absolute number of gut-resident
microbiota-reactive CD4þ T cells is likely to be at least 10
times greater than that in peripheral blood.
Gut-resident bacteria-reactive (CD154þTNF-aþ) T cells
produced high amounts of IFN-gamma, IL17A, and IL2,
while production of IL22, granulocyte macrophage colony-
stimulating factor, and IL4 was generally low (Figure 3Dand Supplementary Figure 3E and F). Interestingly, lamina
propria T cells showed increased IL17A expression and
reduced IFN-gamma production relative to cells with similar
reactivity in peripheral blood (Figure 3D and
Supplementary Figure 3E).Enteric Bacteria-Reactive CD4þ T Cells Are
Clonally Diverse
To assess the clonal diversity of circulating bacteria-
reactive memory CD4þ T cells, we expanded
CFSE-labeled CD4þ T cells using whole bacteria and
autologous irradiated monocytes as antigen presenting
cells (Supplementary Figure 4A).20 S aureus-, M tubercu-
losis-, and SEB-reactive T cells served as controls. Antigen-
reactive T cells proliferated in a major histocompatibility
complex IIdependent manner and were readily detec-
tible after 36 days (Figure 4A and Supplementary
Figure 4BD). Proliferating cells expressed several acti-
vation markers including ICOS, CD25, and OX40 (Figure 4A
and Supplementary Figure 4B, E, and F). Consistent with
the CD154 assay, S aureus, M tuberculosis, and SEB
strongly induced T-cell proliferation (Figure 4A and B and
Supplementary Figure 3B and C).
Flow cytometry analysis revealed a diverse TCR Vb
repertoire in bacteria-reactive T cells, similar to polyclonal
stimulation with phytohemagglutinin but different to
stimulation with SEB, which is known to activate a
restricted Vb repertoire (Figure 4C).30 To directly assess
the clonal diversity of bacteria-reactive CD4þ T cells, we
isolated CFSElow bacteria-reactive memory T cells and
assessed TCR Vb clonotypes by multiplex polymerase
chain reaction and deep sequencing. One hundred and ﬁfty
to eight hundred clonotypes were detected for each
reactivity (Supplementary Figure 4G). The largest clonal
diversity was detected among E coli- and S typhimur-
iumreactive cells, consistent with frequencies observed
in the CD154 assay (see Figure 1B and C and
Supplementary Figure 1B and F). While closely related
species (eg, E coli vs S typhimurium) had 3%8% overlap
in T-cell clonotypes, little clonotype sharing was observed
between T cells reactive to more distantly related bacteria
(Supplementary Figure 3H). Indeed, E coli- and B ani-
malisreactive CD4þ T-cell lines were strongly restimu-
lated when cultured with autologous monocytes loaded
with E coli or B animalis lysates, respectively. In contrast,
E colireactive T cells responded weakly to the closely
related S typhimurium, while B animalisreactive T cells
responded weakly to L acidophilus, F prausnitzii, and C
difﬁcile (Supplementary Figure 5A). These data conﬁrm
the low degree of cross-reactivity predicted from TCR Vb
sequencing.
Microbiota-Reactive Memory CD4þ T Cells Are
Functionally Heterogeneous and Produce
Barrier-Promoting Cytokines
To functionally characterize circulating microbiota-
reactive memory cells, we analyzed CFSElow cells using
Figure 3.Microbiota-reactive CD4þ T cells are enriched in gut tissue. Lamina propria mononuclear cells (LPMCs) were isolated
from non-inﬂamed and tumor-free surgical specimens from colorectal cancer patients. (A) Experimental setup. LPMCs were
stimulated with heat-inactivated bacteria for 812 hours and assessed for intracellular expression of cytokines and CD154. (B)
Estimated microbiota-reactive cells per million CD4þ T cells in adult blood and intestinal tissue from unrelated donors, based
on CD154 staining (n ¼ 17 for control mucosa; n ¼ 2531 for blood). (C) Matched LPMCs and PBMCs were stimulated with
heat-inactivated E coli (blue symbols) or S typhimurium (red symbols), analyzed for CD154 expression, and compared with
respect to the estimated microbiota-reactive cells per million CD4þ T cells. Connected dots represent matched samples. (D)
Frequencies (±SEM) of IL17A, IFN-gamma, and IL22 production by CD154þTNF-aþ memory CD4þ T cells isolated from
LPMCs or PBMCs from unrelated donors after stimulation with heat-inactivated bacteria (n ¼ 1023 donors). Signiﬁcance
calculated between the respective stimulations in control mucosa and peripheral blood. Statistics: (B, D) Mann-Whitney test;
(C) paired t test.
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days. Enteric microbiota-reactive cells produced Th1- and
Th17-related cytokines, including IFN-gamma, IL17A, and
IL22, but only low amounts of the Th2 cytokine IL4, com-
parable to cells reactive toward S aureus or C albicans
(Figure 4D and Supplementary Figure 5B and C). In contrast,
memory T cells reactive toward SEB, M tuberculosis, inﬂu-
enza vaccine components, or tetanus toxoid showed a
polarized Th1 proﬁle with low expression of IL17A
(Figure 4D and Supplementary Figure 5B and C). Boolean
gating revealed a high degree of functional heterogeneity in
expanded microbiota-reactive memory T cells, with
frequent co-expression of IL17A, IL22, and IFN-gamma
(Figure 4E). Bacteria-reactive cells co-expressed the tran-
scription factors RAR-related orphan receptor gt and T-box
expressed in T cells, which are characteristic of Th17 and
Th1 cells, respectively (Figure 4F and G and Supplementary
Figure 5D and E). Intriguingly, a subset of CD4þ T cells
reactive to F prausnitzii, L acidophilus, or B animalis pro-
duced the immunoregulatory cytokine IL10 in addition to
IFN-gamma and IL17A (Supplementary Figure 5F).
Compared to T cells that are reactive toward M tuberculosis
or vaccine antigens, enteric microbiota-reactive T cells are
functionally distinct and produce barrier-promoting and
immunoregulatory cytokines.BA
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Intestinal Stromal and Epithelial Cell Activation
During periods of epithelial damage and exposure to
commensals, activation of microbiota-reactive memory T
cells could promote protective immune responses. To assess
their tissue-modulating capabilities, cell-free supernatants
of microbiota-reactive memory T cells were used to stimu-
late CCD18Co intestinal myoﬁbroblasts and LIM1863
colonic epithelial cells. CCD18Co and LIM1863 cells were
then assessed for expression of various immune response
genes that were selected a priori to represent responses to
major T-cellderived cytokines. Both cell types responded
by expressing several cytokine and chemokine genes known
to be induced by IL17A (including IL1B, CSF2, IL6, CXCL1,
and CXCL8), as well as IFN-gammainducible genes,
including CXCL9, CXCL10, and CXCL11 (Figure 5A and B).31
Conversely, supernatants from SEB-stimulated memory T=
Figure 4.Microbiota-reactive memory CD4þ T cells are clonally
were labeled with CFSE or violet proliferation dye (VPD)-450 an
autologous monocytes. (A) CFSE proﬁles and inducible T-cell co
a representative donor. (B) Percentage of CFSElow CD4þ T cells
Vb expression by proliferating VPDlow cells measured by Vb a
pendent donors is depicted. TCR Vb usage of the differen
Supplementary Table 2. (D) Mean (±SEM) cytokine production
CFSEhigh cells after phorbol myristate acetate/ionomycin stimu
analysis showing each possible combination of IL17A, IFN-gam
from 9 independent donors. (F, G) RAR-related orphan receptor g
proliferating CFSElow cells measured by intracellular staining on d
possible combination of RORgt, T-bet, and GATA-binding fac
independent donors. Statistics: (B) 1-way analysis of variance
variance with Bonferroni’s multiple comparison test.cells (which produce little IL17A) mainly induced
IFN-gammadependent genes. Thus, stimulation of non-
hematopoietic intestinal cells by microbiota-reactive T
cells may promote recruitment and activation of myeloid
cell populations to facilitate pathogen control and tissue
repair.
We next assessed the effects of individual cytokines in
E colireactive T-cell supernatants using combinations of
neutralizing antibodies. This experiment revealed distinct
IFN-gamma and IL17A-/TNF-adependent groups of
response genes in both intestinal epithelial cells and
ﬁbroblasts. IFN-gamma blockade strongly reduced
expression of several chemokine genes, including CXCL9,
CXCL10, CXCL11, CCL2, and CCL7 (IFN-gammadependent
module; Figure 5C and D). Intriguingly, single blockade of
IL17A, IL22, or TNF-a did not affect stromal or epithelial
cell activation (Figure 5C and D). However, combined
blockade of IL17A and TNF-a inﬂuenced a large number
of genes, including CSF2, IL1B, TNF, CXCL1, CXCL8, CXCL5,
CXCL6, and CCL20 (IL17A/TNF-adependent module).
Triple blockade of IFN-gamma, IL17A, and TNF-a
completely inhibited stromal and epithelial cell activation.
IL22 blockade did not affect cytokine or chemokine pro-
duction, but attenuated induction of the antimicrobial
peptide REG3G in LIM1863 cells. Given that the products
of T-cellstimulated stromal and epithelial cells are
highly expressed in the inﬂamed mucosa of IBD patients
(Figures 5E and 7D), this signature might reﬂect the
activation of microbiota-reactive T cells after epithelial
disruption, a key feature of IBD.Microbiota-Reactive CD4þ T Cells in
Inﬂamed Intestinal Tissue Show a T-Helper
17Skewed Phenotype in Patients With
Inﬂammatory Bowel Disease
IBD is thought to arise in part from aberrant adaptive
immune responses to microbiota.8 Human CD4þ T cells in
IBD have been functionally characterized mainly by poly-
clonal stimulation.32–34 Therefore, we evaluated
microbiota-reactive CD4þ T-cell responses in IBD patients
using the CD154 detection approach. Circulating
microbiota-reactive CD4þ T-cell frequencies were
decreased in IBD patients compared with healthy donors,diverse and functionally heterogeneous. Memory CD4þ T cells
d stimulated with heat-inactivated bacteria in the presence of
stimulator (ICOS) expression on days 3 and 6 of stimulation in
of each individual donor (n ¼ 18). (C) Pie charts showing TCR
ntibody staining on day 7 of stimulation. Average of 3 inde-
t reactivities of 3 independent donors is summarized in
frequencies of proliferating CFSElow cells and non-activated
lation (n ¼ 1213 independent donors). (E) Boolean gating
ma, and IL22 production by CFSElow proliferating cells. Data
t (RORgt) and T-box expressed in T cells (T-bet) expression in
ay 7 of stimulation. (G) Boolean gating analysis showing each
tor-3 production by CFSElow proliferating cells. Data from 3
with Sidak’s multiple comparison test; (D) 1-way analysis of
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inﬂamed gut (Figure 6A and Supplementary Figure 6A).
However, intestinal memory CD4þ T cells from IBD pa-
tients did not display reciprocally higher frequencies of
microbial speciﬁcity (Figure 6B and Supplementary
Figure 6B). We next calculated the frequency of memory
CD4þ T cells in inﬂamed mucosae using ﬂow cytometry.
Memory CD4þ T cells were present at higher frequencies
in inﬂamed tissue from IBD patients compared with tissue
from matched non-lesional sites of IBD patients and
healthy controls (Figure 6C). These ﬁndings were
conﬁrmed using a previously published bioinformatics
approach known as CIBERSORT in an independent
cohort35 (Supplementary Figure 6C). Based on both ap-
proaches, memory CD4þ T cells are typically 2- to 4-fold
more frequent in inﬂamed tissue from IBD patients
compared with tissue from healthy controls. Because
inﬂamed tissue contains a higher abundance of memory
CD4þ T cells than healthy mucosa, it can be inferred that
gut-resident microbiota-reactive CD4þ T cells are similarly
enriched in patients with active IBD (Figure 6C,
Supplementary Figure 6C).
To evaluate functional alterations in microbiota-
reactive CD4þ T cells in IBD, intracellular CD154 detec-
tion was combined with cytokine analysis. Compared with
healthy controls, circulating microbiota-reactive CD4þ T
cells from IBD patients displayed increased IL17A and IL2
production, but decreased expression of IFN-gamma
(Figure 7A and Supplementary Figure 6D and E). Inter-
estingly, increased IL17A production was observed in all
enteric bacteria-reactive responses, but not in S aureus, M
tuberculosis, or SEB responses (Figure 7A and
Supplementary Figure 6E and F). These changes were
observed in both Crohn’s disease and ulcerative colitis and
were independent of disease activity or therapy
(Supplementary Figure 6G). However, no difference in IL10
production was observed between healthy donors and IBD
patients (Supplementary Figure 6H). IFN-gamma and
IL17A co-expression is thought to identify pathogenic
CD4þ T cells in mouse colitis models,36 so we assessed
their co-expression in E colireactive memory CD4þ T
cells. Compared with controls, IBD patients displayed=
Figure 5.Microbiota-reactive memory T cells promote intestina
CD4þ T cells from peripheral blood were labeled with CFSE and
autologous monocytes. CD4þCFSElowICOShighcells were ﬂuor
1014 days with anti-CD3/CD28 beads. Expanded cells were
(PMA)/ionomycin for 24 hours to produce conditioned super
speciﬁcities were used to stimulate CCD18Co intestinal myoﬁbro
stimulated cells was measured by quantitative polymerase chai
containing PMA/ionomycin alone). Results of independent stim
Proteobacteria-reactive T cells (S typhimurium and E colire
Firmicutes-reactive T cells (F prausnitzii and L acidophilusr
Supernatants from E colireactive CD4þ T cells were used to st
pretreated with 1 or more cytokine-neutralizing antibodies as
transformed, and plotted as a heat map. Data representative of
biopsies from the Oxford IBD cohort, categorized by endoscop
characteristics of IBD patients are summarized in Supplementar
Sidak’s multiple comparison test.signiﬁcantly increased frequencies of IL-17AþIFN-gamma
cells and a marginal increase in IL17AþIFN-gammaþ cells,
while the IL17AIFN-gammaþ fraction was reduced
signiﬁcantly (Figure 7B). E colireactive CD4þ T cells from
inﬂamed intestinal tissue showed an increase in IL17A
single producers similar to that seen in peripheral blood
(Figure 7C).
Because the Th17-inducing cytokines IL1B, IL6, and
IL23A were highly enriched in the inﬂamed intestinal tissue
of IBD patients (Figure 7D), we reasoned that they might
promote Th17 polarization of bacteria-reactive T cells.
Indeed, treatment of microbiota-reactive CD4þ T cells from
healthy donors and IBD patients with IL1b, IL6, or IL23 for
1 week during stimulation with E coli, S typhimurium, L
acidophilus, or B animalis (CFSE dilution assay) resulted in a
1.5- to 2-fold increase in IL17A production (Figure 7E and
Supplementary Figure 6I).
Taken together, these experiments demonstrate that
circulating and gut-resident microbiota-reactive CD4þ T
cells express increased frequencies of IL17A in IBD. Intes-
tinal tissues from patients with active IBD express gene
modules driven by Th1/Th17-derived cytokines, suggesting
that bacteria-reactive memory cells could contribute to the
tissue response.Discussion
The gastrointestinal tract harbors a large and diverse
population of commensal bacteria, and how the immune
system interacts with them is subject to intense investiga-
tion. Here we used 2 different methodologies to characterize
microbiota-reactive CD4þ T-cell frequencies and pheno-
types in the blood and intestinal tissue of healthy in-
dividuals and those with IBD. For each bacterial strain
tested, the healthy CD4þ T-cell repertoire contains reactive
cells at a frequency of 404000 per million, consistent with
other antigen-reactive memory T cells.37 Microbiota-
reactive CD4þ T cells were mainly of a memory pheno-
type, present in both blood and gut tissue, had a diverse TCR
Vb repertoire, and showed little clonotype sharing. Notably,
microbiota-reactive CD4þ T cells were functionally hetero-
geneous in terms of homing receptor expression andl stromal and epithelial cell activation. Healthy donor memory
stimulated with heat-inactivated bacteria in the presence of
escence-activated cellsorted on day 7 and expanded for
stimulated at equal numbers with phorbol myristate acetate
natants. (A, B) Cell-free supernatants from different T-cell
blasts and LIM1863 colon epithelial cells. Gene expression in
n reaction (qPCR) and normalized to control treatment (media
ulations were pooled together into the following categories:
active); Actinobacteria-reactive T cells (B animalis-reactive);
eactive). Data are from 3 independent T-cell donors. (C, D)
imulate CCD18Co (C) or LIM1863 (D) cells. Supernatants were
indicated. Gene expression was median-normalized, log2
23 independent experiments. (E) qPCR analysis of mucosal
ic assessment of disease activity. Demographic and clinical
y Table 5. Statistics: (A, B, E) 1-way analysis of variance with
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production of IL17A, IFN-gamma, IL22, and TNF-a. In
addition, microbiota-reactive CD4þ T cells were recruited to
sites of inﬂammation and showed increased IL17A pro-
duction in patients with IBD.
Characterizing T-cell responses to bacteria is technically
challenging due to their complex antigenic makeup. We
therefore used the CD154 and CFSE dilution assays, both of
which exploit microbial complexity, to provide large
numbers of antigens. The combination of CFSE dilution and
TCR Vb sequencing allowed us to quantify clonotype het-
erogeneity and sharing between different bacteria-reactive
T cells. Given the phylogenetic similarity of several bacte-
ria used in this study, the paucity of clonotype sharing was
surprising. Nevertheless, enteric bacteria-reactive T cells
could be cross-reactive to other antigens not assessed in this
study, and may have been primed during immune responses
to other targets.38 High interclonal and intraclonal func-
tional heterogeneity in human CD4þ T-cell responses to
microbes and vaccines was observed recently.19 However,
clonotype sharing between different microbial stimuli has
not been studied previously and requires further
investigation.
Microbiota-reactive CD4þ T cells showed substantial
phenotypic and functional heterogeneity. The majority of
circulating enteric bacteria-reactive CD4þ T cells co-
expressed chemokine receptors, including CCR4, CCR6,
and CCR7, while a smaller fraction expressed the gut-related
homing receptors a4b7 and CCR9. These receptors promote
access to secondary lymphoid organs and various mucosal
tissues, including the intestine.4,27 In addition, circulating
and gut-resident microbiota-reactive T cells displayed both
Th17 and Th1 characteristics and, in some cases, produced
IL10.39 Gut-resident cells showed a clear Th17 bias when
compared to circulating populations, which was more pro-
nounced in IBD.
Based on our observations, we can speculate that
continuous sampling of luminal antigens by intestinal
dendritic cells causes low-level stimulation of gut-resident
CD4þ T cells to produce cytokines that support epithelial
integrity, barrier function, and intestinal homeostasis.40,41
Indeed, cytokine production by commensal-reactive CD4þ
T cells might play a more signiﬁcant role in supporting gut
homeostasis than previously thought (Supplementary=
Figure 6. Abundance of circulating and gut-resident enteric
healthy donors or IBD patients were stimulated with the ind
expression. Frequencies (±SEM) of CD154þ cells among C
clinical characteristics of IBD patients are summarized in Sup
(LPMCs) were isolated from inﬂamed surgical specimens fr
specimens from colorectal cancer patients. Isolated LPM
bacteria and analyzed for CD154 expression. Frequencies
ted (n ¼ 1020). (C) LPMCs from endoscopic intestinal b
lesional and non-lesional sites of IBD patients from an indep
represent frequencies of CD45RACD4þ memory T cells a
dots represent matched biopsies. Demographic and clin
Supplementary Table 7. Statistics: (A, B, C) Mann-Whitney
comparison test.Figure 7). However, this homeostatic circuit might be
disrupted in IBD due to dysbiotic changes and/or per-
turbed myeloid cell activity, causing inappropriate T-cell
activation and a pathogenic imbalance of cytokine
production.8
While IL17A is frequently cited as a pathogenic cyto-
kine, it is also critical for promoting mucosal barrier
function and protection from pathogens.31 Absence of
IL17A was recently shown to increase epithelial injury and
compromise barrier function in mouse models of coli-
tis.42,43 Indeed, IL17A is a critical driver of neutrophil
recruitment, and its absence could therefore exacerbate
mucosal inﬂammation by facilitating bacterial invasion and
dispersal.44 Notably, blockade of IL17A in Crohn’s disease
caused disease exacerbation, despite being well tolerated
and therapeutically effective in psoriasis.45 Thus, IL17A
likely plays a key tissue-protective role in humans, sug-
gesting that the increased Th17 polarization of microbiota-
reactive T cells in IBD patients could reﬂect an effort to
bolster tissue integrity.
Host-microbial homeostasis depends on minimizing
contact between micro-organisms and mucosal surfaces via
the combined action of epithelial cells, mucus, IgA, anti-
microbial peptides, and immune cells.1,2 Active immune
responses to gut ﬂora have been linked to disease.8 How-
ever, this concept should be revisited in light of our current
ﬁndings and the observation that healthy individuals
generate antibody responses to commensals.46,47 At least 2
plausible mechanisms could explain the genesis of these
microbiota-reactive responses. First, mucosal dendritic
cells constantly survey the luminal microenvironment and
thereafter migrate to secondary lymphoid tissues to initiate
B- and T-cell responses.48,49 Second, during gastrointes-
tinal infections in mice, immune responses against com-
mensals and pathogens are induced in parallel.50
Continuous luminal sampling of intestinal microbiota and
periodic epithelial breaches during gastrointestinal in-
fections might provide a plethora of memory T cells with
potential reactivity toward newly encountered patho-
gens.6,7 Therefore, contrary to the notion that they promote
inﬂammatory pathology, acquired commensal-reactive T-
cell responses may be essential to promote barrier function
and IL10-mediated immune regulation—2 cornerstones of
intestinal homeostasis.bacteria-reactive CD4þ T cells in IBD. (A) PBMCs from
icated heat-inactivated bacteria and analyzed for CD154
D4þ T cells are depicted (n ¼ 3038). Demographic and
plementary Table 6. (B) Lamina propria mononuclear cells
om IBD patients or non-inﬂamed and tumor-free surgical
Cs were stimulated with the indicated heat-inactivated
(±SEM) of CD154þ cells among CD4þ T cells are depic-
iopsies were obtained from healthy controls or matched
endent Oxford cohort (n ¼ 12 controls and 17 IBD). Dots
mong total live LPMCs from different donors; connected
ical characteristics of IBD patients are summarized in
test; (C) 1-way analysis of variance with Sidak’s multiple
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Supplementary Experimental
Procedures
Human Samples and Cell Isolation
PBMCs were isolated by Ficoll-Paque (GE Healthcare Life
Sciences, Little Chalfont, UK) density gradient centrifugation,
resuspended in phosphate-buffered saline with 2 mM EDTA
and 0.02% bovine serum albumin, and further processed. Gut
specimens were obtained from patients with IBD undergoing
surgery for severe, chronically active, or complicated disease.
Control gut specimens from macroscopically healthy areas
were collected from colorectal cancer patients as non-
inﬂammatory controls. One intestinal pinch biopsy was ob-
tained from healthy donors (colorectal cancer screening, or
other non-IBD related conditions) or IBD patients during
routine endoscopy, from lesional, and non-lesional sites,
attending the John Radcliffe Hospital (Oxford, UK). Inﬂam-
mation status of biopsieswas binarized into either inﬂamed or
uninﬂamed categories based on endoscopic assessment.
Additional information about the analyzed IBD patients can be
found in Supplementary Tables 57.
Lamina propria mononuclear cells were isolated as
described previously.1 In brief, mucosa was dissected and
washed in 1 mM dithiothreitol at room temperature for 15
minutes to remove mucus. Specimens were washed 3 times
with 0.75 mM EDTA at 37C for 45 minutes to detach
epithelial crypts and digested overnight with 0.1 mg/mL
collagenase D (Roche, Indianapolis, IN). Cells were centri-
fuged for 30 minutes in a Percoll gradient and collected at
the 40%60% interface. All solutions were supplemented
with antibiotics (penicillin/streptomycin, 40 mg/mL genta-
micin, and 0.025 mg/mL amphotericin B).
Flow Cytometry
Cells were stained with the following monoclonal anti-
bodies as described2: CD4-BV510 (OKT4), CD4 phycoerythrin
(PE)-Dazzle (RPA-T4), CD3-PE-CF594 or –BV510 (UCHT1),
CD45RA-BV711 (HI100), CD45RO-BV570 (UCHL1), CD161-
eF450 (HP3G10), CCR7-PE (G034H7), CCR2-APC (K036C2),
CCR6-BV605 (G034E3), CCR9-PE-Cy7 (L053E8), CXCR3-PE/
Cy5 (1C6/CXCR3), CCR4-PE-Cy7 (1G1), CCR10-PE (314305),
Integrin b7-FITC/APC (FIB504), CD69-PE-Cy7 (FN50), IL-2-
BV650 (MQ1-17H12), TNF-a-PB (MAb11), CD154-FITC/PE-
Cy5 (24-31), IL-17A BV711 (eBio64DEC17), IL-22-PE-Cy7
(22URTI), IFN-g-AF700 (B27), GM-CSF-APC (BVD2-21C11),
and IL-4-PE (8D4-8) (eBioscience, Biolegend, San Diego, CA
and Becton Dickinson, San Jose, CA). Fluorescein-activated cell
sorting panels contained up to 12 ﬂuorochromes. Compensa-
tion beads were used for compensations (BD Bioscience, San
Jose, CA). TCR Vb usage was assessed using the IOTest Beta
Mark TCR Vbeta Repertoire Kit (Beckman Coulter, Brea, CA).
Samples were acquired on FACS LSRFortessa and FACSLSRII
(Becton Dickinson); 2  105 memory CD4þ T cells were
acquired. Datawere analyzedwith FlowJo (Tree Star, Ashland,
OR) and SPICE. For analysis of cytokine expression by
microbiota-speciﬁc T cells, a minimum of 20 CD4þ CD154þ
TNF-aþ T cells was used; donors with lower events were
excluded.
CD154 Enrichment of Antigen-Speciﬁc T Cells
For magnetic cell separation enrichment of CD4þCD154þ
T cells, CD154 Enrichment and Detection Kit was used (Mil-
tenyi Biotec). Brieﬂy, cells were plated at 5  106/cm2 for
712 hours with heat-inactivated bacteria in the presence of
anti-CD40 blocking antibody (HB14) and anti-CD28 stimu-
lation antibody (CD28.6). Anti-CD40 blockade prevents
down-regulation of CD154, while CD28 co-stimulation
optimizes induction of CD154 expression. For major histo-
compatibility complex II blockade, 10 mg/mL of a pan-HLA
class-II blocking antibody (HLA-DR, DP, DQ; [Tü39]) was
added 30 minutes before bacterial stimulation. Cord and
adult blood analysis was performed identically. Antigen-
presenting cell abundance is similar in cord and adult
blood.3,4
Cross-Reactivity Assay
CD154þ CD4þ T cells were isolated using magnetic cell
separating enrichment and ﬂuorescein activated cell sorting
from total PBMCs after stimulation with E coli Nissle and B
animalis lysates as described. CD154þ CD4þ T cells were
expanded for 1014 days with IL2 and anti-CD3/CD28
beads (beads/T cell ratio, 1:4, Dynals). The expanded T-
cell lines were washed in IL2 free medium and incubated
for 12 hours without IL2 in RPMI-1640 supplemented with
2 mM glutamine, 1% (v/v) non-essential amino acids, 1%
(v/v) sodium pyruvate, penicillin (50 U/mL), streptomycin
(50 mg/mL; all from Invitrogen), and 5% (v/v) human
serum (National Blood Service, Bristol, UK). The expanded
T-cell lines were labeled with CFSE, and then were co-
incubated with autologous monocytes loaded with various
bacterial lysates. T cells were co-cultured with the irradi-
ated autologous monocytes at a ratio of 2:1 for 57 days.
The CFSE dilution was measured at the end of the culture.
Autologous CD14þ monocytes were isolated from PBMC
using anti-CD14 microbeads (Miltenyi Biotec) and frozen
until the T-cell co-culture. Monocytes were thawed down,
irradiated (45 Gy), and then pre-incubated for 3 hours with
bacterial lysates before T-cell co-culture.
Intracellular Cytokine Analysis
For intracellular cytokine staining, cells were restimu-
lated with phorbol myristate acetate (5 ng/mL) and ion-
omycin (500 ng/mL; Sigma) or bacterial lysates. Brefeldin A
(5 mg/mL; Sigma-Aldrich) was added at 2 hours. After 412
hours, cells were stained with ﬁxable viability dye eFluor
780 (eBioscience) and surface markers, ﬁxed with 2%
formaldehyde (Merck), and stained for cytokines in buffer
containing 0.05% saponin (Sigma-Aldrich). In some assays,
cytokine analysis was combined with intracellular CD154
detection, as described previously.5,6
Transcription Factors Staining
Transcription factor expression was analyzed using the
FoxP3 staining buffer set (eBioscience) according to man-
ufacturer’s instructions. Brieﬂy, cells were stained with
ﬁxable viability dye eFluor 780 (eBioscience) and surface
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markers, ﬁxed with 1 ﬁxation/permeabilization buffer,
followed by antibody staining and washing in 1 per-
meabilization buffer. T-box expressed in T cellsPaciﬁc
Blue (4B10) and GATA-binding factor-3Alexa-647 (TWAJ)
were from eBioscience. Related orphan receptor gt-PE
(Q21-559) was from BD Bioscience.
Preparation of Bacterial Lysates
Different bacteria were cultured in their respective
optimal media for 16 hours at 37C, washed in sterile
phosphate-buffered saline and heat-inactivated at 65C for
1 hour, followed by 3 freezethaw cycles. Extremely
oxygensensitive bacteria were provided by Sylvia Dun-
can, University of Aberdeen, after heat inactivation. Sus-
pensions were centrifuged at maximum speed for 15
minutes and supernatants collected. Protein concentration
was quantiﬁed using Nanodrop (Thermo Fisher Scientiﬁc,
Waltham, MA). The following bacterial strains were used:
B vulgatus (Bv 1447), B animalis subsp lactis Bi-07, C
difﬁcile (OXF1003, Toxin AB-), E coli (Nissle 1917), F
prauznitzii (A2-165), L acidophilus (NCFM), R intestinalis
(M50/1), R obeum (A2-162), Salmonella enterica serovar
typhimurium (NCTC 12023), and S aureus (NCTC 6571).
Additional information regarding the bacterial stains is
provided in Supplementary Table 1. Bacterial lysates were
titrated in CFSE dilution assay and an optimal concen-
tration was used (515 mg/mL). Tetanus toxoid (Calbio-
chem, San Diego, CA) and inﬂuenza seasonal vaccine
(OPTAFLU; Novartis, Basel, Switzerland) were used at 5
mg/mL. Heat-killed M tuberculosis (H37Ra) and C albicans
were from InvivoGen (San Diego, CA). Ultrapure
lipopolysaccharide-EB from E coli 0111:B4 (InvivoGen)
was used as a stimulation control. SEB was used at 1
mEBmL (Sigma).
RNA Extraction, Complementary DNA Synthesis,
and Quantitative Polymerase Chain Reaction
Tissue was homogenized using a motor with sterile
RNase/DNase-free disposable pestles (both VWR) in RLT
buffer (Qiagen, Valencia, CA). Cells were lysed directly in RLT
buffer. RNA was isolated using RNeasy Mini kit (Qiagen) or
Quick-RNA MiniPrep kit (Zymo Research, Irvine, CA) followed
by complementary DNA preparation using High-Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Carls-
bad, CA) with random hexamers. Quantitative polymerase
chain reaction (PCR) was performed using a CFX96 (Bio-Rad,
Hercules, CA) orViiA7384-well real-timePCRsystem(Applied
Biosystems)with TaqMan assays (Life Technologies, Carlsbad,
CA), and PrecisionPLUS Mastermix (Primerdesign, South-
ampton, UK). Expression levels were normalized to a
housekeeping (hk) gene (RPLP0) and expressed as 2
ˇ
-
(CTgene-CThk). Heat maps were made using Cluster 3.0 and
Java TreeView (Michael Eisen, Stanford University).
CIBERSORT Analysis
To calculate enrichment of cell populations using
CIBERSORT,7 we analyzed the GSE16879 dataset on default
settings. For each sample, relative expression of PTPRC
(CD45, representing relative leukocyte content) was calcu-
lated separately using median-normalized microarray data.
This value was then multiplied by CIBERSORT cell type
scores (eg, proportion of memory CD4þ T cells in the total
leukocyte fraction) to estimate cell type enrichment levels.
Finally, for cell types of interest, fold differences between
IBD and control specimens were calculated to estimate
relative cell type abundance in active IBD lesions versus
healthy tissue.
T-Cell Receptor Vb Sequencing and Analysis
Memory T cells (3.6  106) were cultured with autolo-
gous monocytes pulsed with heat-inactivated bacteria from
3 healthy donors. Expanded CFSElow ICOSþCD4þ T cells
were sorted into DNase/RNase free water with bovine
serum albumin (10 mg/mL) in 96-well plates (100 cells/
well) and stored at 80C. TCR Vb sequence analysis was
obtained by a series of 3 nested PCR reactions, as described
previously.8 Reverse transcription and preampliﬁcation
were performed with a One-Step RT-PCR kit (Qiagen) using
multiplex PCR with multiple Vb region primers and a Cb
region primer. After the ﬁrst reaction, an aliquot was used
for the second PCR using a set of multiple internally nested
TCR Vb primers and internally nested Cb region primer
with HotStarTaq DNA polymerase kit (Qiagen). In the ﬁnal
PCR reaction, an aliquot of the second PCR was used and
ampliﬁcation was performed using barcoding primers
containing the common 23-base sequence (incorporated
into the second set of Vb primers) and a third internally
nested Cb primer and Illumina Pair-End primers. After the
third PCR reaction, each PCR product should have a unique
set of barcodes incorporated that speciﬁes plate, row, and
column and have Illumina Paired-End sequences that
enabled sequencing on the Illumina MiSeq platform. The
PCR products were combined at equal proportion by vol-
ume, run on a 1.2% agarose gel, and a band around 350 to
380 bp was excised and gel puriﬁed using a Qiaquick gel
extraction kit (Qiagen). Barcoded products were sequenced
on the Illumina MiSeq platform.
Sequence reads were trimmed using ‘Trim Galore’
software (http://www.bioinformatics.babraham.ac.uk/
projects/trim_galore/) with default settings. Reads were
de-multiplexed using a custom Python script according to
the presence of index sequences. A further custom script
then split reads from each well according to the presence
of primer sequences used in the PCR ampliﬁcation. These
reads were then analyzed by MICXR, version 1.6 (http://
www.nature.com/nmeth/journal/v12/n5/full/nmeth.
3364.html) using settings appropriate for the anticipated
TCR locus of origin (A or B). MIXCR provided CDR3 se-
quences along with counts of the number of times each
sequence was observed. Detected CDR3 sequences were
ﬁltered to exclude those with 10 counts per well. There
were 48 wells per donor of SEB-stimulated or
phytohemagglutinin-stimulated cells while there were 96
wells of bacterially stimulated cells. Furthermore, some
wells did not contain any valid TCR sequences after
ﬁltering for low read counts, suggesting that ampliﬁcation
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or sequencing had failed for those wells. To permit com-
parisons of the number of TCR sequences between plates
with differing numbers of successful wells, counts were
scaled to the theoretical maximum of 96 wells.
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Supplementary Figure 1. Bacterial strains used in the study and detection of enteric bacteria-speciﬁc memory CD4þ T cells
(related to Figure 1). (A) Bacterial species are listed according to their family and phylum classiﬁcation. Colored circles relate
the bacteria to their gaseous requirement. (B) Frequencies of CD154þ cells among peripheral CD4þ T cells in adults after short-
term stimulation with heat-inactivated bacteria. Dots represent different donors (n ¼ 30). (C) Representative ﬂow cytometric
plots of different stimulations showing CD154 expression against CD4 within CD3þ cells after short-term stimulation with heat-
inactivated bacteria. Frequencies of CD154 within CD4þ T cells are depicted. (D) Representative plot of CD69 and ICOS
expression on CD4þCD154þ T cells after short-term stimulation with heat-inactivated S typhimurium. (E) PBMCs were
stimulated with the indicated heat-inactivated bacteria in presence or absence of major histocompatibility complex II (MHCII)
blocking antibodies and analyzed for CD154 expression. Percentage of reduction in CD154þ frequencies after MHCII blockade
compared to control treated is depicted. Frequencies (±SEM) of 3 independent experiments are depicted (n ¼ 56 inde-
pendent donors). (F) Estimated microbiota-reactive cells per million CD4þ T cells in adult blood (n ¼ 30). The numbers of
microbiota-reactive T cells were calculated based on the frequencies of CD4þCD154þ T cells. Background (no microbe
stimulation) was subtracted from bacterial stimulations. Signiﬁcance calculated in relation to lipopolysaccharide (LPS) stim-
ulation. (G) Frequencies ± SEM of CD154þ cells among CD4þ T cells in adult (n ¼ 30) or cord blood (n ¼ 3) after short-term
stimulation with heat-inactivated bacteria. Statistics: (E, G) Mann-Whitney test; (C, F) 1-way analysis of variance with Sidak’s
multiple comparison test; ns, not signiﬁcant; *P  .05; ***P  .01; ***P  .001; ****P  .0001.
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Supplementary Figure 2. Detection and characterization of microbiota-speciﬁc memory CD4þ T cells (related to Figure 1
and 2). (A) Frequencies of CD154þ cells among naïve and memory peripheral CD4þ T cells in adults after short-term stimu-
lation with heat-inactivated bacteria. Dots represent different donors (n ¼ 30). (B) Percentage of memory cells within
CD4þCD154þ T cells. Each symbol represents an antigen-reactive population from 1 individual; the line indicates the mean of
experiments performed independently with blood obtained at different times (n ¼ 1930). Signiﬁcance calculated in relation to
total CD4þ T cells. (C) Percentages of cytokine-expressing cells among memory CD4þCD45RACD154þ T cells are shown.
Frequencies (±SEM) of 27 independent donors are depicted. (D) Surface marker and chemokine receptor expression fre-
quencies among CD4þ CD45RA CD154þ and CD4þ CD45RA CD154 T cells after short-term stimulation with B animalis.
Frequencies within CD4þ CD45RACD154þ or CD4þ CD45RA CD154 T cells are depicted. Statistics: (A) Mann-Whitney
tests; (B) 1-way analysis of variance with Sidak’s multiple comparison test; ns, not signiﬁcant; *P  .05; **P  .01;
***P  .001; ****P  .0001.
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Supplementary Figure 3. Detection and characterization of microbiota-speciﬁc CD4þ T cells within gut-resident memory T
cells (related to Figure 3). (A) Representative ﬂow cytometry plots showing CD45RA, integrin b7, CD69, CCR7, and CD127
expression in gut-resident CD3þCD4þ T cells. Data representative of 10 independent donors. (B, C) Gating strategy for
identiﬁcation of enteric bacteria-speciﬁc memory CD4þ T cells in lamina propria mononuclear cell (LPMCs) and PBMCs after
stimulation with heat-inactivated E coli in a representative donor. (D) LPMCs were stimulated with heat-inactivated bacteria
and analyzed for CD154 expression. Estimated gut resident microbiota-reactive cells per million CD4þ T cells compared with
adult blood is depicted (n ¼ 17 for control mucosa; n ¼ 2531 for blood). (E, F) Cytokine production by CD4þCD154þTNF-aþ
T cells after short-term stimulation with the indicated heat-inactivated bacteria. Frequencies (±SEM) of 1023 independent
donors. Signiﬁcance calculated between the respective stimulations in control mucosa and peripheral blood. Statistics: (D, E,
F) Mann-Whitney test; ns, not signiﬁcant; *P  .05; **P  .01; ***P  .001; ****P  .0001.
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Supplementary Figure 4. Expansion and detection of microbiota-speciﬁc memory CD4þ T cells (related to Figure 4). Total
memory CD4þ T cells were isolated, labeled with CFSE, and cultured with autologous irradiated monocytes in the presence or
absence of the indicated heat-inactivated bacteria and blocking antibodies to major histocompatibility complex II (MHCII). (A)
Experimental setup. (B) Shown are the CFSE proﬁles and ICOS expression on days 3 and 6 of stimulation in a representative
donor. (C) Frequencies (±SEM) of CFSElow proliferating cells after stimulation with S aureus and M tuberculosis (n ¼ 521).
Data representative of 510 independent experiments. Each dot represents an independent donor. (D) Frequencies (±SEM) of
CFSElow proliferating CD4þ T cells in presence or absence of anti-MHCII. Data representative of 2 independent experiments.
(E, F) CFSE proﬁles and expression of CD25 and OX40 on day 6 of stimulation in a representative donor. (F) Geometric mean
and frequencies (±SEM) of ICOS, CD25, and OX40 expression on CFSElowCD4þ T cells on day 6. (G) Number of unique TCRb
clonotypes detected in bacteria-reactive CD4þ T cells. TCR Vb sequencing was performed from 3 independent donors. Each
circle represents an independent donor. TCR Vb usage of the different reactivities of 3 independent donors is summarized in
Supplementary Table 3. (H) Heat map showing the frequency of shared clonotypes between different bacteria-reactive CD4þ
T-cell responses. SEB and phytohemagglutinin (PHA) expanded memory T cells were used as controls. Data from 3 inde-
pendent donors. The CDR3 sequences are summarized in Supplementary Table 4. Statistics: (C, D, F) 1-way analysis of
variance with Sidak’s multiple comparison test; ns, not signiﬁcant; *P  .05; **P  .01; ***P  .001; ****P  .0001.
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Supplementary Figure 5. Cross-reactivity, cytokine production, and transcription factor expression by antigen-reactive
memory CD4þ T cells (related to Figure 5). (A) CD154þ memory CD4 T cells from PBMCs were sorted after short-term
stimulation with E coli and B animalis lysates and expanded them for 1014 days with CD3/CD28 and IL2. The E coli
Nissle- and B animalisreactive T cell lines were CFSE-labeled and then co-incubated with autologous monocytes loaded with
the various bacterial lysates. Frequencies (±SEM) of CFSElow proliferating cells after 5 days of stimulation with the indicated
bacteria are shown. Data from 36 independent donors. (BF) Total memory CD4þ T cells were isolated, labeled with CFSE
and cultured with autologous irradiated monocytes in the presence of the indicated heat-inactivated bacteria or antigens.
(B, C) Production of cytokines by proliferating CFSElow cells measured by intracellular staining after phorbol myristate acetate
(PMA)/ionomycin stimulation on day 7 of primary stimulation with monocytes and heat-inactivated bacteria. Frequencies
(±SEM) of 313 independent donors are depicted. Each dot represents an independent donor. (D, E) Related orphan receptor
gt (RORgt), T-box expressed in T cells (T-bet), and GATA-binding factor-3 (GATA-3) expression on day 7 of primary stimulation
with monocytes and inﬂuenza seasonal vaccination or heat-inactivated S aureus in a representative donor. (E) Boolean gating
analysis showing each possible combination of RORgt, T-bet, and GATA-3 production by CFSElow proliferating cells. Data
generated from 3 independent donors. (F) Production of IL10 by expanded CFSElow CD4þ cells after PMA/ionomycin stim-
ulation. Frequencies (±SEM) and IFN-gamma/IL17A co-expression within IL10þ and IL10 cells are depicted from 58 in-
dependent donors. Statistics: (A, C) 1-way analysis of variance with Sidak’s multiple comparison test; (F) Kruskal-Wallis test
with Dunn’s multiple comparison; ns, not signiﬁcant; ***P  .001; ****P  .0001.
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Supplementary Figure 6. Functional characteristics of enteric bacteria-reactive CD4þ T cells in IBD (related to Figure 7). (A)
PBMCs isolated from healthy donors or IBD patients were stimulated with the indicated heat-inactivated bacteria and analyzed
for CD154 expression. Frequencies (±SEM) of reactive CD154þ cells among CD4þ T cells in peripheral blood are depicted (n ¼
3038). Demographic and clinical characteristics of IBD patients are summarized in Supplementary Table 6. (B) Lamina
propria mononuclear cell (LPMCs) were isolated from inﬂamed surgical specimens from IBD patients or non-inﬂamed and
tumor-free surgical specimens from colorectal cancer patients. Isolated LPMCs were stimulated with the indicated heat-
inactivated bacteria and analyzed for CD154 expression. Frequencies (±SEM) of reactive CD154þ TNF-aþ cells among
CD4þ T cells in peripheral blood are depicted (n ¼ 1020). (C) Microarray analysis of intestinal biopsies obtained at endoscopy
(n ¼ 6 controls, 24 ulcerative colitis (UC) and 37 Crohn’s disease (CD); Gene Expression Omnibus entry GSE16879). The
relative abundance of memory CD4þ T cells in control and inﬂamed IBD tissue was estimated in silico using CIBERSORT (see
Supplementary Methods for details). (DF) PBMCs isolated from healthy and IBD patients were stimulated with the indicated
heat-inactivated bacteria or SEB and analyzed for CD154 expression and intracellular cytokine expression. Demographic and
clinical characteristics of IBD patients are summarized in Supplementary Table 6. (D) IL2 expression in CD154þ TNF-aþ
memory CD4þ T cells after stimulation with the indicated heat-inactivated bacteria or SEB. Frequencies (±SEM) of 23-33
independent donors. Each dot represent an independent donor. (E, F) IL17A, IFN-gamma, IL22, and IL2 expression in CD154þ
TNF-aþ memory CD4þ T cells after stimulation with the indicated heat-inactivated bacteria. Each dot represents an inde-
pendent donor. Demographic and clinical characteristics of IBD patients are summarized in Supplementary Table 6. (G) IL17A
expression in CD154þ TNF-aþ memory CD4þ T cells after stimulation with S typhimurium. IBD patients were categorized by
disease phenotype (UC, CD), disease activity according to clinical notes, and current treatment. (H) Total memory CD4þ T cells
were isolated from healthy controls or IBD patients blood, labeled with CFSE and cultured with autologous irradiated
monocytes in the presence of the indicated heat-inactivated bacteria or antigens. Production of IL10 by expanded CFSElow
CD4þ cells after phorbol myristate acetate (PMA)/ionomycin stimulation on day 7 of stimulation. Frequencies (±SEM) are
depicted from 911 independent donors. (I) CD4þCD45ROþCD45RACD25CD8 memory CD4þ T cells were isolated from
healthy controls or IBD patients blood, labeled with CFSE, and stimulated with autologous monocytes pulsed with B
animalis in the presence or absence of the indicated cytokines. Data represent mean (±SEM) fold changes in IL17A or IFN-
gamma expression frequencies relative to cells expanded without cytokines. Statistics: (AE, GH) Mann-Whitney test; (F)
1-way analysis of variance with Sidak’s multiple comparison test; ns, not signiﬁcant; *P  .05; **P  0.01; ***P  .001;
****P  .0001.
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Supplementary Figure 7.Microbiota-speciﬁc memory T-cell responses in intestinal homeostasis and inﬂammation.
Microbiota-speciﬁc memory CD4þ T cells are abundant in peripheral blood and mucosa. Luminal sampling of intestinal
microbiota by dendritic cells and repetitive epithelial breaches after birth might induce CD4þ T-cell responses targeted to-
wards intestinal bacteria. Enteric bacteria-speciﬁc CD4þ T cells produce barrier-protective cytokines, such as IL17A, IFN-
gamma, and IL22. Furthermore, certain commensal-speciﬁc CD4þ T cells also produce IL10. We speculate that the cytokine
production by commensal-speciﬁc CD4þ T cells might play a signiﬁcant role in supporting gut homeostasis and the mutualistic
relationship with intestinal microbiota. In inﬂammation, epithelial break down and leakage leads to increased availability of
luminal antigens and bacterial stimuli, which activate the innate system and the expression of Th17-inducing cytokines (IL1b,
IL6, and IL23). Recruited microbiota-speciﬁc memory CD4þ T cells accumulate in inﬂamed mucosa and are polarized toward
more IL17A production. Activated memory cells express IL17A, TNF-a, and IFN-gamma, which stimulate intestinal cells, such
as stromal and epithelial cells, to express various chemokine ligands and cytokines. This may promote recruitment and
activation of myeloid cell populations.
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